Disease - Diabetes
Business and Managed Care Diabetes and Health Resource Kit
More than 18.2 million Americans have diabetes, many of them the workforce. This online diabetes and health resource kit is designed to help businesses and managed care companies to assess the impact of diabetes in the workplace. It also provides easy-to-understand information for employers to help their employees manage their diabetes and take steps toward reducing the risk for diabetes-related complications such as heart disease.
A Closer Look at Diabetes, 2002
The number of Americans diagnosed with diabetes jumped 49 percent from 1990 to 2000. Diabetes is the main cause of kidney failure, new cases of blindness, and lower limb amputations, and is a major risk factor for heart disease and stroke. In this six-page brochure, a joint project between the American Diabetes Association and NPC, we take a closer look at the factors that influence drug spending for the treatment of diabetes.
Diabetes: What You Should Know, 2003
Almost 6 million Americans have undiagnosed diabetes. This brief article, written in partnership with the Chronic Disease Directors and published by NAPS outlines key facts for consumers about diabetes, its risk factors, diagnosis, and preventive measures.
Disease Management for Diabetes, 2004
This monograph presents 65 studies detailing the impact of educational interventions on diabetes treatment and management as well as information
on diabetes disease management programs in development. It is intended to serve as a guide for those interested in developing disease management programs for the treatment of diabetes. Fact sheet available.
The Health and Productivity Cost Burden of the “Top 10” Physical and Mental Health Conditions Affecting Six Large U.S. Employers, by Ron Z. Goetzel, et al., Journal of Occupational and Environmental Medicine, Vol. 45, No.1, January 2003
This article identifies the top 10 most costly physical and mental health conditions faced by six large employers in their health benefits programs. The research identifies costs associated with each condition including direct medical costs and the indirect costs associated with days absent from the job and short-term disability costs.
Health Care & Productivity, 2000
This newsletter, designed for employers, details how newer drug therapies have direct and profound effects on productivity and the bottom lines of employers who select and provide health benefits.
The Importance of Individualized Pharmaceutical Therapy in the Treatment of Diabetes Mellitus, by David B. Nash, MD, MBA, et al., Disease Management, Vol. 4, Suppl. 1, 2001
Individualized pharmaceutical care for patients with diabetes is necessary due to the variety among the patient population, the frequency and severity of concurrent medical conditions, and other factors that influence individual health and treatment options. This 22-page supplement to the journal Disease Management emphasizes how proper care tailored to individual patient needs can improve overall health and reduce more serious complications. Fact sheet available.
Pharmaceuticals and Productivity: Investing in Human Capital, 2001
(Note: ~20mb)
New therapies have the potential to produce economic savings and benefits both outside of the health care system (indirect savings) and within the system (direct savings). This report explores the question of whether spending on pharmaceuticals has a positive payoff.
The Silver Book: Chronic Disease and Medical Innovation in an Aging Nation
The Silver Book, a project of the Alliance for Aging Research is an almanac of hundreds of facts, statistics, graphs, and information from close to 100 agencies, organizations and experts. It is a searchable database that is constantly updated and expanded in order to highlight the latest research and data on the burden of chronic disease and the value of investing in medical research. The Silver Book database is searchable by specific terms or by sections. The database is also interactive, allowing users to submit data from additional studies and reports.
The Value of Disease Management: Balancing Cost and Quality in the Treatment of Diabetes Mellitus, by Jeann Lee Gillespie, PharmD, MS, Disease Management, Vol. 5, No. 1, 2002
The article examines the value of disease management in both improving the quality of care received and managing costs associated with the treatment of diabetes. Case studies from state Medicaid initiatives and private sector HMO programs are provided, as well as a bibliography of 56 studies citing disease management interventions and outcomes for further reference.
|
